Evidence map›Paper›PMID 26658015›Full record

ReviewCurrent opinion in allergy and clinical immunology2016

Allergen-encoded signals that control allergic responses.

Hui-Ying Tung, Cameron Landers, Evan Li, Paul Porter, Farrah Kheradmand, David B Corry

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in allergy and clinical immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Hui-Ying TungaDepartment of Pathology & Immunology bTranslational Biology and Molecular Medicine Program cDepartment of Medicine dBiology of Inflammation Center, Baylor College of Medicine eMichael E. DeBakey VA Center for Translational Research on Inflammatory Diseases, Houston, Texas, USA.
Cameron Landers
Evan Li
Paul Porter
Farrah Kheradmand
David B Corry
Baylor College of Medicine · USHouston Methodist · USMichael E. DeBakey VA Medical Center · US

Funding

Molecular Phenotypes for Lung DiseasesR01HL095382 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI CORRY, DAVID B, KHERADMAND, FARRAH · 2008 to 2011
$2.8M
Ancillary T Cell Based Studies in SPIROMICSR01HL110883 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI KHERADMAND, FARRAH · 2012 to 2015
$1.6M
Th1 and Th17 Mediators in Experimental EmphysemaR01HL117181 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI CORRY, DAVID B, KHERADMAND, FARRAH · 2013 to 2016
$1.5M
Carbon Black Induced Activation of Lung APCsI01BX002221 · VA · MICHAEL E DEBAKEY VA MEDICAL CENTER · PI CORRY, DAVID B · 2013 to 2016
–
Regulation of Innate and Adaptive Immunity in Human COPD and EmphysemaI01CX000104 · VA · MICHAEL E DEBAKEY VA MEDICAL CENTER · PI KHERADMAND, FARRAH · 2009 to 2021
–
BLRD VA I01 BX002221CSRD VA I01 CX000104NHLBI NIH HHS HL11718NHLBI NIH HHS R01 HL095382NHLBI NIH HHS R01 HL110883NHLBI NIH HHS R01 HL117181
6 · The paper itself

Abstract

purpose of reviewThe purpose is to review the important recent advances made in how innate immune cells, microbes, and the environment contribute to the expression of allergic disease, emphasizing the allergen-related signals that drive allergic responses. RECENT

findingsThe last few years have seen crucial advances in how innate immune cells such as innate lymphoid cells group 2 and airway epithelial cells and related molecular pathways through organismal proteinases and innate immune cytokines, such as thymic stromal lymphopoietin, IL-25, and IL-33 contribute to allergy and asthma. Simultaneously with these advances, important progress has been made in our understanding of how the environment, and especially pathogenic organisms, such as bacteria, viruses, helminths, and especially fungi derived from the natural and built environments, either promote or inhibit allergic inflammation and disease. Of specific interest are how lipopolysaccharide mediates its antiallergic effect through the ubiquitin modifying factor A20 and the antiallergic activity of both helminths and protozoa. SUMMARY: Innate immune cells and molecular pathways, often activated by allergen-derived proteinases acting on airway epithelium and macrophages as well as additional unknown factors, are essential to the expression of allergic inflammation and disease. These findings suggest numerous future research opportunities and new opportunities for therapeutic intervention in allergic disease.

Indexed as

Immunity, InnateAllergensAnimalsHumansHypersensitivitySignal TransductionAllergens

Identifiers

PMID26658015
PMCPMC4863991
OpenAlexW2219720488

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.